Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001104659-26-076958
Filing Date
2026-06-24
Accepted
2026-06-23 21:28:29
Documents
109

Document Format Files

Seq Description Document Type Size
1 S-1 limn-20260331xs1.htm   iXBRL S-1 3012316
2 EX-5.1 limn-20260331xex5d1.htm EX-5.1 10427
3 EX-23.1 limn-20260331xex23d1.htm EX-23.1 3169
4 EX-FILING FEES limn-20260331xexfees.htm   iXBRL EX-FILING FEES 24737
5 GRAPHIC limn-20260331xs1002.jpg GRAPHIC 15060
6 GRAPHIC limn-20260331xs1003.jpg GRAPHIC 40278
7 GRAPHIC limn-20260331xex5d1001.jpg GRAPHIC 4303
  Complete submission text file 0001104659-26-076958.txt   12702027

Data Files

Seq Description Document Type Size
8 EX-101.SCH limn-20260331.xsd EX-101.SCH 93288
9 EX-101.CAL limn-20260331_cal.xml EX-101.CAL 55886
10 EX-101.DEF limn-20260331_def.xml EX-101.DEF 513326
11 EX-101.LAB limn-20260331_lab.xml EX-101.LAB 533298
12 EX-101.PRE limn-20260331_pre.xml EX-101.PRE 795166
114 EXTRACTED XBRL INSTANCE DOCUMENT limn-20260331xs1_htm.xml XML 1427996
115 EXTRACTED XBRL INSTANCE DOCUMENT limn-20260331xexfees_htm.xml XML 4398
Mailing Address 12611 HIDDENCREEK WAY UNIT C CERRITOS CA 90703
Business Address 12611 HIDDENCREEK WAY UNIT C CERRITOS CA 90703 213-273-5453
Liminatus Pharma, Inc. (Filer) CIK: 0001971387 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-296986 | Film No.: 261112839
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)